Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Ho Song

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Plos One|February 7, 2017
Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinomaSeulki Cho, Tae Sup Lee, In Ho Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 19, 2019
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imagingNunzio Denora, Chaedong Lee, Rosa Maria Iacobazzi, et al.
Polymers|April 10, 2019
An Oligoimide Particle as a Pickering Emulsion StabilizerYu-Jin Cho, Dong-Min Kim, In-Ho Song, et al.
The Journal of Rheumatology|July 17, 2014
Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Pharmaceutics|June 24, 2022
Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with <sup>89</sup>Zr Radioisotope in Mice and RatsHojun Choi, Myung-Yoon Kim, Dae-Hwan Kim, et al.
Annals of the Rheumatic Diseases|July 5, 2022
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trialDésirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, et al.
Arthritis Research & Therapy|April 10, 2023
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studiesXenofon Baraliakos, Roberto Ranza, Andrew Östör, et al.
Plos One|January 26, 2019
PET imaging of HER2 expression with an 18F-fluoride labeled aptamerHyun Jeong Kim, Jun Young Park, Tae Sup Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 10, 2019
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled TrialRoy Fleischmann, Aileen L Pangan, In-Ho Song, et al.
Molecules and Cells|July 5, 2005
Use of SSR markers to complement tests of distinctiveness, uniformity, and stability (DUS) of pepper (Capsicum annuum L.) varietiesYong-Sham Kwon, Je-Min Lee, Gi-Bum Yi, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Plos One|February 7, 2017
Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinomaSeulki Cho, Tae Sup Lee, In Ho Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 19, 2019
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imagingNunzio Denora, Chaedong Lee, Rosa Maria Iacobazzi, et al.
Polymers|April 10, 2019
An Oligoimide Particle as a Pickering Emulsion StabilizerYu-Jin Cho, Dong-Min Kim, In-Ho Song, et al.
The Journal of Rheumatology|July 17, 2014
Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Pharmaceutics|June 24, 2022
Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with <sup>89</sup>Zr Radioisotope in Mice and RatsHojun Choi, Myung-Yoon Kim, Dae-Hwan Kim, et al.
Annals of the Rheumatic Diseases|July 5, 2022
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trialDésirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, et al.
Arthritis Research & Therapy|April 10, 2023
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studiesXenofon Baraliakos, Roberto Ranza, Andrew Östör, et al.
Plos One|January 26, 2019
PET imaging of HER2 expression with an 18F-fluoride labeled aptamerHyun Jeong Kim, Jun Young Park, Tae Sup Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 10, 2019
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled TrialRoy Fleischmann, Aileen L Pangan, In-Ho Song, et al.
Molecules and Cells|July 5, 2005
Use of SSR markers to complement tests of distinctiveness, uniformity, and stability (DUS) of pepper (Capsicum annuum L.) varietiesYong-Sham Kwon, Je-Min Lee, Gi-Bum Yi, et al.
Pageof 11